AMERICAN HEALTHCARE REIT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.51 USD | -.--% |
|
-.--% | -.--% |
| 03/04 | Truist Securities Trims Price Target on American Healthcare REIT to $16 From $17, Maintains Buy Rating | MT |
| 22/03 | Transcript : American Healthcare REIT, Inc., Q4 2023 Earnings Call, Mar 22, 2024 |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 1,638 | - | - |
| Enterprise Value (EV) 1 | 3,481 | 3,437 | 3,434 |
| P/E ratio | -50 x | -122 x | - |
| Yield | 7.14% | 7.22% | 7.14% |
| Capitalization / Revenue | 0.85 x | 0.79 x | 0.74 x |
| EV / Revenue | 1.8 x | 1.65 x | 1.56 x |
| EV / EBITDA | 11.3 x | 10.5 x | 10.2 x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | 0.99 x | 1.07 x | 1.14 x |
| Nbr of stocks (in thousands) | 1,31,598 | - | - |
| Reference price 2 | 14.01 | 14.01 | 14.01 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 1,867 | 1,931 | 2,079 | 2,199 |
| EBITDA 1 | - | - | 308.8 | 328.4 | 337.6 |
| EBIT 1 | - | 70.92 | 114.9 | 137.4 | 158.9 |
| Operating Margin | - | 3.8% | 5.95% | 6.61% | 7.23% |
| Earnings before Tax (EBT) 1 | - | -76.22 | -0.257 | 34.2 | 57.03 |
| Net income 1 | -81.3 | -71.47 | -38.54 | -16.77 | - |
| Net margin | - | -3.83% | -2% | -0.81% | - |
| EPS 2 | -1.240 | -1.080 | -0.2800 | -0.1150 | - |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | 1.000 | 1.012 | 1.000 |
| Announcement Date | 17/03/23 | 21/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|
| Net sales 1 | 482.6 | 491.1 | 500.6 | 507.1 | 514.4 | 525.3 |
| EBITDA 1 | - | 72.46 | 75.95 | 77.52 | 79.68 | 79.6 |
| EBIT 1 | 25.66 | 23.24 | 28.6 | 30.45 | 32.66 | 29.83 |
| Operating Margin | 5.32% | 4.73% | 5.71% | 6% | 6.35% | 5.68% |
| Earnings before Tax (EBT) 1 | -31.07 | -9.925 | 2.104 | 5.042 | 2.522 | 6.909 |
| Net income 1 | -27.42 | -15.97 | -7.815 | -7.801 | -6.952 | -2.051 |
| Net margin | -5.68% | -3.25% | -1.56% | -1.54% | -1.35% | -0.39% |
| EPS 2 | -0.4100 | -0.1200 | -0.0400 | -0.0300 | -0.0400 | -0.0200 |
| Dividend per Share 2 | - | 0.2500 | 0.2500 | 0.2500 | 0.2500 | 0.2500 |
| Announcement Date | 21/03/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 1,844 | 1,800 | 1,796 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | 5.971 x | 5.481 x | 5.321 x |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | -22% | -19.1% | -20.6% |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | - | 14.10 | 13.10 | 12.30 |
| Cash Flow per Share 2 | - | - | 1.340 | 1.460 | - |
| Capex 1 | - | - | 30.4 | 32.2 | - |
| Capex / Sales | - | - | 1.57% | 1.55% | - |
| Announcement Date | 17/03/23 | 21/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
14.01
USD
Average target price
15.75
USD
Spread / Average Target
+12.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.57% | 19.25B | |
| -1.26% | 13.76B | |
| +0.10% | 7.58B | |
| -10.80% | 5.82B | |
| +10.32% | 3.51B | |
| +1.82% | 3.36B | |
| -1.26% | 3.22B | |
| -2.65% | 2.87B | |
| +16.92% | 2.84B |
- Stock Market
- Equities
- AHR Stock
- GRAH Stock
- Financials American Healthcare REIT, Inc.